NCT02497365View on ClinicalTrials.gov

Besifloxacin in Bacterial Keratitis

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

July 31, 2019

Conditions
Bacterial Keratitis
Interventions
DRUG

Besifloxacin

DRUG

Tobramycin and Cefazolin

Fortified Tobramycin and Cefazolin eye drops

Trial Locations (1)

H4A 3S9

McGill Academic Eye Center, Montreal

All Listed Sponsors
lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

NCT02497365 - Besifloxacin in Bacterial Keratitis | Biotech Hunter | Biotech Hunter